A1ZN34:BVMF
ایسٹرا زینیکا
R$139.90
0.00%
(0.00) 1 دن
16 اکتوبر, 5:06:00 PM GMT -3 · BRL
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoA1ZN34 کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
کھولیں
R$143.33
اعلی
R$143.33
کم
R$138.81
مارکیٹ کی سرمایہ کاری
2.59 کھرب
اوسط والیوم
892.00
والیوم
1.25 ہزار
52 ہفتے میں اعلی
R$190.40
52 ہفتے کا کم
R$129.06
بقایہ شیئرز
1.55 ارب
ملازمین کی تعداد
96 ہزار
کھولیں
R$143.33
اعلی
R$143.33
کم
R$138.81
مارکیٹ کی سرمایہ کاری
2.59 کھرب
اوسط والیوم
892.00
والیوم
1.25 ہزار
52 ہفتے میں اعلی
R$190.40
52 ہفتے کا کم
R$129.06
بقایہ شیئرز
1.55 ارب
ملازمین کی تعداد
96 ہزار
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
Yahoo Finance
·
15 گھنٹے پہلے
Summit Therapeutics (SMMT) Stock Fair Value Edges Higher After AstraZeneca Deal And Trial Focus
Insider Monkey
·
1 دن پہلے
AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity?
Traders Union
·
1 دن پہلے
AstraZeneca shares technical analysis: Upward price move confirms strong near-term momentum
The Twelfth Magpie
·
1 دن پہلے
While the market panics about the FTSE 100, Citi just raised its AstraZeneca target to £186
پروفائل
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
ایسٹرا زینیکا کے بارے میں
CEOPascal Soriot
ملازمین96.1 ہزار
تاریخ قیام6 اپریل، 1999
ہیڈ کواٹرزکیمبرج, کیمبرجشائر, سلطنت متحدہ
سیکٹر-
ویب سائٹastrazeneca.com